Print
Share
RSS
Donate
News
AZCERT, sponsor of CredibleMeds, is delighted to announce the addition of two new members to our Board of Directors. Doctors Jim Galloway and Jim Tisdale bring talent and broad expertise to the Board of AZCERT and CredibleMeds. For more information…
We’re excited to announce that CredibleMeds was recently featured as a trusted, informative resource in a recent article published in P&T Community’s Pharmacovigilance Forum. The article focuses on the many common medicines that may increase the risk…
Four New Drug Added to CredibleMeds® Lists and Mobile Apps for QTdrugs/DTA Lists
Because the safe use of the CredibleMeds® lists of medications requires that the user have the most up-to-date lists of drugs, we are informing you of the addition of Midostaurin (anti-cancer drug) to the Possible Risk (PR) List.
Because the safe use of the CredibleMeds® lists of medications requires that the user have the most up-to-date lists of drugs, we are informing you of these changes to the QTdrugs.org lists: 1. Add Ribociclib and Necitumumab to Possible Risk List 2.…
Text for citing the use of the QTdrugs List or the CredibleMeds.org website:
Woosley RL, Heise CW, Gallo T, Woosley RD, Lambson J. and Romero KA, www.CredibleMeds.org, QTdrugs List, [Accession Date], AZCERT, 1457 E. Desert Garden Dr., Tucson, AZ 85718
Copyright: The CredibleMeds® website is intended for personal and professional use only. Its content is protected by U.S. Copyright. Unauthorized use for commercial purposes is prohibited.